MedTrace Logo

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

NCT01788527 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 325

Last updated 2017-07-19

No results posted yet for this study

Summary

The primary objective of the study is to determine if RT CGM (Real Time-Continuous Glucose Monitoring) can improve glycemic control in women with T1D who are pregnant or planning pregnancy.

Conditions

  • Type 1 Diabetics Who Are Pregnant or Planning Pregnancy

Interventions

DEVICE

CGM

Real Time Continuous Glucose Monitoring

Sponsors & Collaborators

  • Sunnybrook Research Institute

    collaborator OTHER

  • Jaeb Center for Health Research

    collaborator OTHER

  • Cambridge University Hospitals NHS Foundation Trust

    collaborator OTHER

  • University of Cambridge

    collaborator OTHER

  • Mount Sinai Hospital, Canada

    lead OTHER

Principal Investigators

  • Denice Feig, MD · MOUNT SINAI HOSPITAL

  • Helen Murphy, MB BCh BAO FRACP MD · Cambridge University Hospital NHS Foundation Trust and University of Cambridge

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States
  • Canada
  • Ireland
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01788527 on ClinicalTrials.gov